about
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapyAtopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disordersBrain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolinStimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actionsAberrant immune responses in a mouse with behavioral disorders.Mercury induces inflammatory mediator release from human mast cells.Neurotensin is increased in serum of young children with autistic disorderPerinatal stress, brain inflammation and risk of autism-review and proposal.Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression.Neuro-inflammation, blood-brain barrier, seizures and autism.Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.Anesthetic considerations in pediatric mastocytosis: a review.Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6.Luteolin and thiosalicylate inhibit HgCl(2) and thimerosal-induced VEGF release from human mast cells.Autism spectrum disorders and allergy: observation from a pediatric allergy/immunology clinic.A case series of a luteolin formulation (NeuroProtek®) in children with autism spectrum disorders.An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.A Cohort Study Comparing Women with Autism Spectrum Disorder with and without Generalized Joint Hypermobility.
P2860
Q21560915-24E9D18C-A1CE-4C2D-8FEE-3C7D096DB689Q26746354-7296AED8-6C76-4E96-973A-33FA20092D27Q26802187-F7D062C3-B59A-49ED-BBA4-EA9EFD965DE3Q28484407-56BB84DB-AF4B-4EE6-AB1B-796ABBE7603FQ31025723-A958562A-D90F-4F85-984C-517AA408611AQ33774385-4C69C136-22ED-483E-B163-FC59D6C159BFQ34114124-C1A57D85-D5E2-4450-ABFE-DAB58AD36495Q34285045-F2454EAE-1804-466E-B5E1-4237476627A6Q34321423-35963CF4-823D-41F7-A174-AD6993E7F470Q35800334-5E505FCD-A7B2-4F9A-AAF9-DB9B2C621AACQ37661363-E998B918-31BA-4336-9AE7-BF0BE287065CQ38081373-BFAA22F8-737B-405B-83FF-76F584DFA666Q39324090-F8B4F92C-EB5E-496D-A426-5395702FD384Q41270272-E5061D1C-8BCA-4F2F-A8DE-C34C0872959DQ42756906-3C11EA88-06CF-400B-B8AE-39CC5C72AEEEQ44845516-018233F8-9A3B-42CB-82FF-473493D94AD0Q48474072-7F30A18C-8192-4EF5-B4C0-BDE2AD2EE83EQ52331711-2D9DC632-8711-45D3-B219-7913A2D3121EQ52347510-93900F10-802F-4E00-BD53-BE7842B04488
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Autism spectrum disorders and mastocytosis.
@en
Autism spectrum disorders and mastocytosis.
@nl
type
label
Autism spectrum disorders and mastocytosis.
@en
Autism spectrum disorders and mastocytosis.
@nl
prefLabel
Autism spectrum disorders and mastocytosis.
@en
Autism spectrum disorders and mastocytosis.
@nl
P2860
P1476
Autism spectrum disorders and mastocytosis.
@en
P2093
Theoharis C Theoharides
P2860
P304
P356
10.1177/039463200902200401
P577
2009-10-01T00:00:00Z